Cargando…
CYFRA 21-1 and Placental Growth Factor as Screening Markers for Endometriosis
BACKGROUND: This study evaluated the performance of serum CYFRA 21-1 and placental growth factor (PIGF) as screening markers for endometriosis. MATERIAL/METHODS: In this prospective study included 81 female patients who underwent laparoscopy to treat benign ovarian tumors. Serum samples were obtaine...
Autores principales: | Cho, Hye-yon, Kyung, Min Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377587/ https://www.ncbi.nlm.nih.gov/pubmed/30737365 http://dx.doi.org/10.12659/MSM.912787 |
Ejemplares similares
-
CYFRA 21-1 in urine: a diagnostic marker for endometriosis?
por: Gjavotchanoff, Risto
Publicado: (2015) -
Postoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I pulmonary adenocarcinoma
por: He, Ying, et al.
Publicado: (2017) -
Evaluation of CYFRA 21.1 as a Dedifferentiation Marker of Advanced Thyroid Cancer
por: Malapure, Sumeet Suresh, et al.
Publicado: (2020) -
Prognostic value of serum CYFRA21-1 and CEA for non-small-cell lung cancer
por: Zhang, Zhi-Hui, et al.
Publicado: (2015) -
Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer
por: Nakata, B, et al.
Publicado: (2004)